NDRG1 and neoplasm: This emphasizes the importance of future work to profile a much larger number of breast and other types of cancer cells to establish the proportion of different tumours that are resistant to Akt inhibitors and also display elevated SGK1 as well as elevated NDRG1 phosphorylation that is not suppressed by Akt inhibitors.